NCT01788722View on ClinicalTrials.gov

Regulatory Post Marketing Surveillance Study in Korea

CompletedOBSERVATIONAL
Enrollment

3,223

Participants

Timeline

Start Date

July 19, 2013

Primary Completion Date

August 11, 2017

Study Completion Date

August 11, 2017

Conditions
Endometriosis
Interventions
DRUG

Dienogest (Visanne, BAY86-5258)

Patients in daily life clinical practice treatment receiving Visanne (dienogest 2mg) according to indication on the label.

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01788722 - Regulatory Post Marketing Surveillance Study in Korea | Biotech Hunter | Biotech Hunter